Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical differences between beta-adrenergic blocking agents: implications for therapeutic substitution.

W H Frishman

    American Heart Journal
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AIDS and the heart: Clinicopathologic assessment.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
    Same author

    ACE inhibitors and the arterial wall. Introduction.

    Postgraduate medicine·2009
    Same author

    Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.

    Minerva medica·2006
    Same author

    Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.

    Drugs of today (Barcelona, Spain : 1998)·2003
    Same author

    Alcohol as a cardioprotective agent.

    Heart disease (Hagerstown, Md.)·2002
    Same author

    Cardiopulmonary resuscitation 2000.

    Heart disease (Hagerstown, Md.)·2002

    Beta blockers have significant differences in how they work and are processed by the body. Careful selection and monitoring are crucial for effective treatment and to avoid adverse drug interactions.

    Area of Science:

    • Pharmacology
    • Cardiology

    Background:

    • Beta blockers possess distinct properties affecting receptor selectivity, sympathomimetic activity, and alpha-adrenergic blockade.
    • Significant pharmacokinetic variations exist, including absorption, metabolism, lipid solubility, protein binding, and renal clearance.

    Purpose of the Study:

    • To highlight the critical differences among beta blockers.
    • To emphasize the importance of considering these differences in clinical decision-making.
    • To discuss the implications of concurrent drug administration and therapeutic substitution.

    Main Methods:

    • Review of pharmacological and pharmacokinetic properties of beta blockers.
    • Analysis of drug interactions and clinical implications.
    • Consideration of patient-specific factors, including age and concurrent therapies.

    Related Experiment Videos

    Main Results:

    • Differences in selectivity, activity, and pharmacokinetics necessitate individualized treatment approaches.
    • Concurrent medications can alter beta blocker efficacy and safety profiles.
    • Therapeutic substitution requires careful monitoring and potential retitration to ensure equivalence.

    Conclusions:

    • Appropriate beta blocker selection is vital for optimizing patient outcomes.
    • Understanding drug interactions and patient variability is essential, especially in elderly populations.
    • Individualized monitoring and management are key when switching or adding medications in beta blocker therapy.